| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2025 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 1,255 | $28.36 | $35,596.82 | -1.0% | +4.5% | - | |
| Aug 1, 2025 | NTRA Natera, Inc. | Marcus Gail Boxer | Director | Sell | 2,496 | $133.17 | $332,394.65 | -16.4% | +43.6% | - | |
| Aug 1, 2025 | NOTV Inotiv, Inc. | Neff R Matthew92 | Director | Sell | 2,000 | $1.91 | $3,818.00 | -1.3% | -30.7% | - | |
| Aug 1, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 3,000 | $132.89 | $398,657.37 | -0.8% | +43.6% | - | |
| Aug 1, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 5,807 | $132.88 | $771,656.35 | -1.7% | +43.6% | - | |
| Aug 1, 2025 | A Agilent Technologies, Inc. | McDonnell Padraig71 | President And CEO | Sell | 2,000 | $113.45 | $226,900.00 | -5.3% | +26.3% | - | |
| Jul 29, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 388 | $105.31 | $40,860.28 | -9.4% | +42.4% | - | |
| Jul 29, 2025 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 2,154 | $105.31 | $226,837.74 | -38.5% | +42.4% | - | |
| Jul 29, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 5,064 | $138.36 | $700,670.43 | -1.9% | +41.5% | - | |
| Jul 28, 2025 | NTRA Natera, Inc. | Sheena Jonathan46 | - | Sell | 479 | $139.81 | $66,968.18 | -0.2% | +39.3% | - | |
| Jul 28, 2025 | MEDP Medpace Holdings, Inc. | Burwig Susan E64 | Exec. VP, Operations | Sell | 7,500 | $450.14 | $3,376,050.00 | -11.5% | +31.7% | - | |
| Jul 28, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 2,206 | $139.81 | $308,417.11 | -1.7% | +39.3% | - | |
| Jul 28, 2025 | MEDP Medpace Holdings, Inc. | Ewald Stephen P59 | General Counsel &Corp. Secy. | Sell | 3,000 | $450.00 | $1,350,000.00 | -22.5% | +31.7% | - | |
| Jul 28, 2025 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 48,487 | $451.69 | $21,901,093.03 | -4.8% | +31.7% | - | |
| Jul 28, 2025 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer And EVP | Sell | 452 | $6.57 | $2,969.64 | -0.4% | +57.4% | - | |
| Jul 28, 2025 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 1,710 | $139.81 | $239,072.19 | -1.1% | +39.3% | - | |
| Jul 28, 2025 | PSNL Personalis, Inc. | Tachibana Aaron68 | CFO And COO | Sell | 641 | $6.57 | $4,211.37 | -0.4% | +57.4% | - | |
| Jul 28, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 6,092 | $139.81 | $851,712.16 | -3.5% | +39.3% | - | |
| Jul 28, 2025 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 1,994 | $139.81 | $278,777.75 | -1.0% | +39.3% | - | |
| Jul 28, 2025 | NTRA Natera, Inc. | Rabinowitz Matthew59 | Executive Chairman | Sell | 1,718 | $139.81 | $240,190.66 | - | +39.3% | - | |
| Jul 25, 2025 | TMO Thermo Fisher Scientific Inc. | Pettiti Gianluca63 | Executive Vice President | Sell | 400 | $479.98 | $191,992.00 | -1.8% | +19.6% | - | |
| Jul 24, 2025 | MEDP Medpace Holdings, Inc. | Brady Kevin M.45 | CFO &Treasurer | Sell | 12,000 | $454.23 | $5,450,760.00 | -66.7% | +20.0% | - | |
| Jul 24, 2025 | MEDP Medpace Holdings, Inc. | Geiger Jesse J60 | President | Sell | 41,801 | $453.11 | $18,940,451.11 | -53.4% | +20.0% | - | |
| Jul 24, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 2,170 | $139.94 | $303,668.67 | -0.8% | +33.3% | - | |
| Jul 23, 2025 | TWST Twist Bioscience Corp | Finn Patrick John73 | President And COO | Sell | 2,232 | $35.74 | $79,773.91 | -0.9% | -7.3% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.